These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 2721810
1. Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss. Jones IR, Owens DR, Luzio SD, Hayes TM. Diabete Metab; 1989; 15(1):11-22. PubMed ID: 2721810 [Abstract] [Full Text] [Related]
7. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Vilsbøll T, Krarup T, Madsbad S, Holst JJ. Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441 [Abstract] [Full Text] [Related]
8. [Behavior of plasma insulin and GIP in obese patients subjected to biliopancreatic bypass]. Gianetta E, Bloom SR, Sarson DL, Civalleri D, Bonalumi U, Friedman D, Adami GF, Pitton L, Brignole E, Traverso E, Scopinaro N. Boll Soc Ital Biol Sper; 1980 Oct 15; 56(19):1922-8. PubMed ID: 7006641 [Abstract] [Full Text] [Related]
9. Meal frequency; does it determine postprandial lipaemia? Murphy MC, Chapman C, Lovegrove JA, Isherwood SG, Morgan LM, Wright JW, Williams CM. Eur J Clin Nutr; 1996 Aug 15; 50(8):491-7. PubMed ID: 8863008 [Abstract] [Full Text] [Related]
10. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, Goldfine A. Obes Res; 2003 Aug 15; 11(8):919-24. PubMed ID: 12917494 [Abstract] [Full Text] [Related]
11. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects. de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O. Ann Nutr Metab; 2007 Aug 15; 51(2):134-8. PubMed ID: 17536190 [Abstract] [Full Text] [Related]
12. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia. Ebert R, Creutzfeldt W. Acta Diabetol Lat; 1989 Aug 15; 26(1):1-15. PubMed ID: 2665406 [Abstract] [Full Text] [Related]
16. Beta-endorphin, insulin, ACTH and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss. Giovannini C, Ciucci E, Clementi R, Cugini P, Facchinetti F, Negri M. Horm Metab Res; 1990 Feb 15; 22(2):96-100. PubMed ID: 2157655 [Abstract] [Full Text] [Related]
17. Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese human subjects. Tappy L, Chiolero R, Randin JP, Burckhardt P, Felber JP. Horm Metab Res; 1986 Dec 15; 18(12):821-6. PubMed ID: 3546047 [Abstract] [Full Text] [Related]
18. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity. Salera M, Giacomoni P, Pironi L, Cornia G, Capelli M, Marini A, Benfenati F, Miglioli M, Barbara L. J Clin Endocrinol Metab; 1982 Aug 15; 55(2):329-36. PubMed ID: 7045154 [Abstract] [Full Text] [Related]
19. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus. Mazzaferri EL, Starich GH, Lardinois CK, Bowen GD. J Clin Endocrinol Metab; 1985 Aug 15; 61(2):313-21. PubMed ID: 4008608 [Abstract] [Full Text] [Related]
20. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity. Boutari C, Stefanakis K, Simati S, Guatibonza-García V, Valenzuela-Vallejo L, Anastasiou IA, Connelly MA, Kokkinos A, Mantzoros CS. Cardiovasc Diabetol; 2024 May 18; 23(1):174. PubMed ID: 38762719 [Abstract] [Full Text] [Related] Page: [Next] [New Search]